Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02302612 · ClinicalTrials.gov registry record · NA

The CREATE Wellness Study

A NA study of Hypertension and Diabetes, sponsored by Kaiser Permanente.

Completed
Registry status
NA
Development phase
647
Enrollment target
1
Study location

NCT02302612 is a NA study of Hypertension and Diabetes that has completed, run by Kaiser Permanente. The registered enrollment target is 647 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02302612, a NA study of Hypertension and Diabetes, has completed, sponsored by Kaiser Permanente.

COMPLETED
Registry status
NA
Development phase
647 participants
Enrollment target
1
Study location

Study Summary

Cardiovascular disease (CVD) is the leading cause of death in the U.S. Efforts to improve CVD risk factors often fall short in complex patients with multiple co-morbid conditions, a growing, expensive, and high-risk segment of the U.S. population. The investigators are testing a multi-component behavioral intervention designed to help complex patients with CVD and other concurrent chronic conditions to become more effective agents of their own care.

Interventions

  • BEHAVIORAL CREATE Wellness
  • OTHER Usual Care Control

Study Locations (1)

California

  • Kaiser Permanente San Jose Sabrina Wood, BA (510) 891-3551 Sabrina.B.Wood@kp.org - San Jose

Trial Details

FieldValue
Enrollment Target 647 participants
Start Date 2015-01
Est. Completion 2018-09-30
Phase NA

Sponsor

Kaiser Permanente

294 total trials

What the Registry Record Tells You About NCT02302612

The ClinicalTrials.gov registry entry for NCT02302612 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 647 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (82% lower). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which CREATE Wellness is the first listed.

NCT02302612 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02302612 about?

NCT02302612 is a clinical study titled "The CREATE Wellness Study". Cardiovascular disease (CVD) is the leading cause of death in the U.S. Efforts to improve CVD risk factors often fall short in complex patients with multiple co-morbid conditions, a growing, expensive, and high-risk segment of the U.S. population. The investigators are testing a multi-component beha...

What is the current status of trial NCT02302612?

This trial is currently completed. It is a NA study. The enrollment target is 647 participants. The study started on 2015-01. Estimated completion is 2018-09-30.

What conditions does trial NCT02302612 study?

This clinical trial studies the following conditions: Hypertension, Diabetes, Dyslipidemia, Heart Disease.

What interventions are being tested in trial NCT02302612?

The interventions under investigation include: CREATE Wellness (BEHAVIORAL), Usual Care Control (OTHER).

Who is sponsoring clinical trial NCT02302612?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02302612 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.